Deutsche Bank’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.41M Buy
24,831
+2,381
+11% +$634K ﹤0.01% 1201
2025
Q4
$5.53M Buy
22,450
+1,071
+5% +$225K ﹤0.01% 1262
2025
Q3
$3.77M Buy
21,379
+2,244
+12% +$336K ﹤0.01% 1441
2025
Q2
$2.63M Sell
19,135
-2,602
-12% -$382K ﹤0.01% 1545
2025
Q1
$3.92M Sell
21,737
-3,624
-14% -$610K ﹤0.01% 1361
2024
Q4
$3.97M Buy
25,361
+9,750
+62% +$1.73M ﹤0.01% 1442
2024
Q3
$2.84M Buy
15,611
+3,341
+27% +$644K ﹤0.01% 1556
2024
Q2
$2.25M Sell
12,270
-539
-4% -$90.5K ﹤0.01% 1578
2024
Q1
$2.28M Sell
12,809
-6,021
-32% -$836K ﹤0.01% 1595
2023
Q4
$2.34M Buy
18,830
+5,331
+39% +$591K ﹤0.01% 1599
2023
Q3
$1.57M Buy
13,499
+365
+3% +$44.5K ﹤0.01% 1478
2023
Q2
$1.54M Sell
13,134
-4,199
-24% -$429K ﹤0.01% 1752
2023
Q1
$1.39M Buy
17,333
+3,917
+29% +$308K ﹤0.01% 1898
2022
Q4
$1.06M Buy
13,416
+1,165
+10% +$86.5K ﹤0.01% 2016
2022
Q3
$854K Sell
12,251
-1,997
-14% -$144K ﹤0.01% 2060
2022
Q2
$936K Sell
14,248
-881
-6% -$54.8K ﹤0.01% 2231
2022
Q1
$1.01M Buy
15,129
+191
+1% +$11.9K ﹤0.01% 2336
2021
Q4
$1.04M Buy
14,938
+583
+4% +$33.9K ﹤0.01% 2414
2021
Q3
$749K Sell
14,355
-335
-2% -$19.8K ﹤0.01% 2791
2021
Q2
$999K Buy
14,690
+825
+6% +$57.6K ﹤0.01% 2770
2021
Q1
$1.07M Buy
13,865
+9
+0.1% +$654 ﹤0.01% 2621
2020
Q4
$832K Buy
13,856
+709
+5% +$35.4K ﹤0.01% 2567
2020
Q3
$566K Buy
13,147
+5,030
+62% +$218K ﹤0.01% 2572
2020
Q2
$336K Buy
8,117
+3,040
+60% +$146K ﹤0.01% 2843
2020
Q1
$220K Sell
5,077
-64
-1% -$3.35K ﹤0.01% 2902
2019
Q4
$283K Buy
5,141
+2,062
+67% +$101K ﹤0.01% 3028
2019
Q3
$105K Sell
3,079
-1,917
-38% -$85.7K ﹤0.01% 3522
2019
Q2
$200K Sell
4,996
-10,378
-68% -$339K ﹤0.01% 3828
2019
Q1
$505K Buy
+15,374
New +$362K ﹤0.01% 3441
2018
Q4
Sell
-22,930
Closed -$403K 5287
2018
Q3
$403K Buy
+22,930
New +$385K ﹤0.01% 3896

Other funds holding KRYS